Trastuzumab Emtansine: A Review of Its Adjuvant Use in Residual Invasive HER2-Positive Early Breast Cancer
Katherine A. Lyseng‐Williamson
Topics & Concepts
TrastuzumabTrastuzumab emtansineMedicineTaxaneAntibody-drug conjugateOncologyBreast cancerInternal medicineTolerabilityPopulationAdjuvantMetastatic breast cancerAdverse effectCancerPharmacologyImmunologyAntibodyMonoclonal antibodyEnvironmental healthHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchBreast Cancer Treatment Studies